MedTrace Logo

Oxytocin and Dopamine's Effect on Vicarious Optimism

NCT03891095 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 156

Last updated 2019-03-26

No results posted yet for this study

Summary

To investigate the effect of intranasal Oxytocin and L-DOPA's effect on vicarious optimism.

Conditions

  • Oxytocin Group
  • L-DOPA Group
  • Placebo Group

Interventions

DRUG

Oxytocin

intranasally administrated

DRUG

L-DOPA

orally administered

DRUG

Placebos

intranasally administrated and orally administered

Sponsors & Collaborators

  • Yale University

    collaborator OTHER

  • Beijing Normal University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
TRIPLE
Model
CROSSOVER

Eligibility

Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-12-01
Primary Completion
2019-01-15
Completion
2019-01-16

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03891095 on ClinicalTrials.gov